Please assess the completion status of the following clinical trial:

Trial Title: Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically proven previously untreated invasive carcinoma of the uterine cervix~  * Squamous cell carcinoma~ * Adenosquamous carcinoma~ * Adenocarcinoma~* TNM classification stage IIIB or IVA (FIGO classification stage IB, IIA, IIB, IIIA, IIIB, or IVA)~* Cytologically or histologically proven metastases to the para-aortic lymph nodes~* No more than 8 weeks since diagnosis~* No metastases to scalene nodes, intraperitoneal metastases, or metastases to other organs outside the radiation field at the time of original clinical and surgical staging~  * Negative CT scan of the chest~* Patients with ureteral obstruction must be treated with stent or nephrostomy tube~PATIENT CHARACTERISTICS:~Age:~* 18 and over~Performance status:~* GOG 0-2~Life expectancy:~* At least 6 months~Hematopoietic:~* Absolute neutrophil count at least 1,500/mm\^3~* Platelet count at least 100,000/mm\^3~Hepatic:~* Bilirubin no greater than 1.5 times normal~* SGOT no greater than 3 times normal~Renal:~* Creatinine less than 2.0 mg/dL~* No renal abnormalities (e.g., pelvic kidney, horseshoe kidney, or renal transplantation) requiring modification of radiation fields~Other:~* Not pregnant~* No septicemia or severe infection~* No other invasive malignancy within the past 3 years except nonmelanoma skin cancer~PRIOR CONCURRENT THERAPY:~Biologic therapy:~* Not specified~Chemotherapy:~* No prior cytotoxic chemotherapy for this or other malignancy~Endocrine therapy:~* Not specified~Radiotherapy:~* No prior radiotherapy for this or other malignancy~* No prior radiotherapy to pelvis or abdomen~Surgery:~* Not specified~Other:~* No other prior therapy for this malignancy

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Radiation therapy plus concurrent weekly chemotherapy (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).